February 16, 2026
The exhibition traces how artists shaped the visual legacy of Alcott’s beloved novel.
February 13, 2026
Astronomy talks to University of Cincinnati physicist Jessica Muir about an international project examining dark energy. The project could help explain why the universe is expanding at an accelerating rate.
February 13, 2026
Slushy snowmelt isn’t just a nuisance, scientists say. It can send a toxic flood of road salt, sand and car exhaust, as well as dog poop, into rivers and streams, The University of Cincinnati College of Medicine's Yevgen Nazarenko, PhD, assistant professor of environmental and industrial hygiene in the Department of Environmental and Public Health Sciences, recently told The New York Times that research has shined a light on how pollution from all sorts of vehicles — planes, cars, trucks — can get trapped in the snow.
February 12, 2026
MSN UK highlighted University of Cincinnati Cancer Center researchers studying the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.
February 12, 2026
Economists and politicians have weighed the benefits of different theoretical models for years, but a lack of direct, empirical evidence showing the macroeconomic effects of fiscal policy has made it difficult to argue for or against government funding at the local level. That’s why University of Cincinnati economics professor David Brasington, PhD, published a new study called “Fiscal policy and economic activity: New Causal Evidence” in the Scandinavian Journal of Economics. By examining decades of levy renewal data across the state of Ohio, the study estimates the impact of property taxes on income beyond theoretical projections.
February 12, 2026
The University of Cincinnati reached $346 million in sponsored research awards in fiscal year 2025, up 6.6% increase over the previous year. Additionally, funding for clinical trials at UC climbed, with $88 million in industry-sponsored awards and $33 million in federally sponsored awards.
February 11, 2026
University of Cincinnati research examining how public art and murals influence foot traffic, neighborhood vitality and economic development is now shaping planning conversations well beyond Cincinnati.
February 11, 2026
The University of Cincinnati’s Fabiano Nery, MD, PhD, has received a five-year, approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to launch a clinical trial testing two new nonpharmacological treatments for teens and young adults with depression.
February 10, 2026
At the College of Engineering and Applied Science, students have the opportunity to engage in meaningful research work with expert faculty. Vinay Chandra Patnala was drawn to the University of Cincinnati to further his knowledge in the field of civil engineering by pursuing a master's degree. Focusing on projects related to steel connections and increasing structural efficiency, Patnala was named Graduate Student Engineer of the Month by CEAS.
February 10, 2026
Following a highly competitive national search, the University of Cincinnati Cancer Center has appointed David Gius, MD, PhD, as its next director.
February 9, 2026
Research from the University of Cincinnati College of Medicine, recently published in the journal Nature Communications, is revealing how immune cells in the adult brain regulate the generation of new neurons.
February 6, 2026
MSN, Bioengineer and other outlets highlight a new study by researchers at the University of Cincinnati who developed a novel AI to predict substance use disorder.
February 5, 2026
A new study by the University of Cincinnati uses a novel artificial intelligence to predict substance use disorder-defining behaviors with up to 83% accuracy.
February 5, 2026
MedPage Today highlighted research led by the University of Cincinnati's Joseph Broderick that found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).
February 4, 2026
The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.